Page last updated: 2024-11-05

butenolide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Butenolides are a class of organic compounds that are characterized by a five-membered ring containing a lactone (cyclic ester) and a double bond. They are known for their diverse biological activities and are frequently encountered as structural motifs in natural products. Butenolides are often studied for their potential medicinal applications. For instance, some butenolides have shown anti-inflammatory, antimicrobial, and anticancer effects. Research into butenolide synthesis focuses on developing efficient and environmentally friendly methods for their production. The study of butenolides has contributed significantly to our understanding of natural product chemistry and their potential for drug discovery.'

butenolide: inhibits experimental allergic encephalomyelitis in rats [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

butenolide : A gamma-lactone that consists of a 2-furanone skeleton and its substituted derivatives. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID10341
CHEMBL ID166223
CHEBI ID38118
MeSH IDM0045598

Synonyms (100)

Synonym
hsdb 8151
5-17-09-00112 (beilstein handbook reference)
unii-8kxk25h388
8kxk25h388 ,
crotonic acid, 4-hydroxy-, gamma-lactone
.gamma.-crotonolactone
nsc197009
nsc-197009
.gamma.-hydroxycrotonic acid lactone
isocrotonolactone
crotonolactone
2-butenoic acid-.gamma.-lactone
2-buten-4-olide
.delta..alpha.,.beta.-butenolide
4-hydroxy-2-butenoic acid lactone
4-hydroxy-2-butenoic acid .gamma.-lactone
2(5h)-furanone
497-23-4
.delta..alpha.,.beta.-butolide
2-butenolide
2-butenoic acid, .gamma.-lactone
butenolide
nsc-51296
nsc51296
nsc 197009
einecs 207-839-3
4-hydroxycrotonic acid gamma-lactone
2-butenoic acid, 4-hydroxy-, gamma-lactone
brn 0383585
crotonic acid, 4-hydroxy-, gamma-lactone (6ci,7ci)
2-butenoic acid-gamma-lactone
gamma-crotolactone
2-(5h)-furanone
delta,alpha,beta-butenolide
ccris 5722
2-butenoic acid gamma-lactone
but-2-en-4-olide
furan-2(5h)-one
alpha,beta-crotonolactone
2-oxo-2,5-dihydrofuran
gamma-crotonolactone
CHEBI:38118 ,
gamma-hydroxycrotonic acid lactone
vihaedvkxsouat-uhfffaoysa-
inchi=1/c4h4o2/c5-4-2-1-3-6-4/h1-2h,3h2
2(5h)-furanone, 98%
AKOS000268618
2h-furan-5-one
C17601
CHEMBL166223 ,
A7404
bdbm50360798
FT-0608698
AM20100212
crotonic acid, 4-hydroxy-, .gamma.-lactone
fema no. 4138
5-oxo-2,5-dihydrofuran-3-yl ester
4-hydroxy-2-butenoic acid .gamma.-lactone [fhfi]
cratone
2,5-dihydrofuranone
.delta.,.alpha.,.beta.-butenolide
2-butenoic acid, 4-hydroxy-, .gamma.-lactone
.beta.-crotonolactone
2(5h)furanone
(5h)-furan-2-one
5h-furan-2-one
5h-furanone
.alpha.,.beta.-crotonolactone
.gamma.-crotolactone
DTXSID7075422
4-hydroxy-2-butenoic acid gamma-lactone
2,5-dihydrofuran-2-one
CS-W008270
mfcd00005376
5 h-furan-2-one
4-hydroxy-2-butenoic acid laquo gammaraquo -lactone
laquo gammaraquo -crotonolactone
2-buten-1,4-olide
2-butenoic acid, 4-hydroxy-, laquo gammaraquo -lactone
alpha,alpha,beta-butolide
laquo deltaraquo ,alpha,beta-butenolide
laquo gammaraquo -crotolactone
2(5h)-furanone (laquo gammaraquo -crotonolactone)
2-butenoic acid-laquo gammaraquo -lactone
2-oxo-2,5-dihydrofuran(2-[5h]-furanone)
laquo gammaraquo -hydroxycrotonic acid lactone
crotonic acid, 4-hydroxy-, laquo gammaraquo -lactone
J-506134
BBL103594
?-crotonolactone
STL557404
Q4596886
SY017893
BCP15247
EN300-80159
SB60895
HY-W008270
g-crotonolactone
2_5h_furanone
Z1219048777

Research Excerpts

Overview

Butenolide is an effective anti-macrofouling compound derived from a marine Streptomyces sp., but its antibiofilm efficacy remains largely unexplored. It inhibits ship hull fouling by a variety of marine organisms.

ExcerptReferenceRelevance
"Butenolide is an environmentally friendly antifouling natural product, but its efficiency and mechanism in preventing biofilm formation have not been examined. "( Anti-biofilm effect of a butenolide/polymer coating and metatranscriptomic analyses.
Chiang, H; Ding, W; Ma, C; Qian, PY; Tam, C; Xu, Y; Zhang, G; Zhang, W, 2018
)
2.23
"Butenolides are an emerging family of signaling molecules in "( Identification of a butenolide signaling system that regulates nikkomycin biosynthesis in
Li, D; Li, Y; Liu, X; Tan, H; Tian, Y; Wang, W; Zhang, J, 2018
)
2.25
"Butenolide is an effective anti-macrofouling compound derived from a marine Streptomyces sp., but its antibiofilm efficacy remains largely unexplored."( Butenolide, a Marine-Derived Broad-Spectrum Antibiofilm Agent Against Both Gram-Positive and Gram-Negative Pathogenic Bacteria.
Hu, ZL; Liang, J; Xu, Y; Yin, Q; Zhang, L; Zhang, W; Zhang, Y, 2019
)
2.68
"Butenolide is a mycotoxin produced by several toxigenic Fusarium species. "( In ovo exposure of a Fusarium mycotoxin butenolide induces hepatic and renal oxidative damage in chick embryos, and antioxidants provide protections.
Peng, SQ; Wang, HJ; Wang, YM, 2009
)
2.06
"Butenolide is a very promising antifouling compound that inhibits ship hull fouling by a variety of marine organisms, but its antifouling mechanism was previously unknown. "( Butenolide inhibits marine fouling by altering the primary metabolism of three target organisms.
He, L; Liu, C; Qian, PY; Xu, Y; Zhang, H; Zhang, YF, 2012
)
3.26

Actions

ExcerptReferenceRelevance
"Butenolide caused an increase in the ratio of weakly to strongly immobilized components (W/S ratio) in a manner of concentration-dependent, indicating conformational changes in membrane proteins occurred."( The oxidative damage of butenolide to isolated erythrocyte membranes.
Peng, SQ; Wang, GQ; Wang, MW; Wang, YM; Yan, CH; Yang, HY; Zhou, Q, 2007
)
1.37

Toxicity

ExcerptReferenceRelevance
" In this study, we evaluated the cytotoxicity of BUT on chondrocytes and the possible toxic mechanism with the aim of understanding the pathogenesis and of directing future therapeutic interventions for KBD."( Butenolide induced cytotoxicity by disturbing the prooxidant-antioxidant balance, and antioxidants partly quench in human chondrocytes.
Cao, J; Chen, J; Li, S; Peng, S; Shi, Z; Yang, B; Zhang, Z, 2009
)
1.8
"625 mg/L showed and differentiation similar to that of the control embryos (=no observed adverse effect concentration; NOAECwec)."( Study of embryotoxicity of Fusarium mycotoxin butenolide using a whole rat embryo culture model.
Guo, J; Huang, WP; Lin, BW; Peng, SQ; Shen, JL; Wang, YM; Wu, J; Yan, CH; Yuan, HT; Zhang, LS, 2011
)
0.63
"This study evaluated the potential adverse effects of butenolide, a promising antifouling compound, using the marine medaka (Oryzias melastigma), a model fish for marine ecotoxicology."( Comparative safety of the antifouling compound butenolide and 4,5-dichloro-2-n-octyl-4-isothiazolin-3-one (DCOIT) to the marine medaka (Oryzias melastigma).
Au, DW; Chen, L; Gao, Z; Qian, PY; Xu, Y; Ye, R, 2014
)
0.91
" They are preferentially toxic to insects while displaying a low toxicity toward vertebrates, and this selective toxicity has resulted in the rapid and ubiquitous use of these compounds."( Acute and chronic toxicity of neonicotinoid and butenolide insecticides to the freshwater amphipod, Hyalella azteca.
Bartlett, AJ; Brown, LR; de Solla, SR; Gillis, PL; Hedges, AM; Intini, KD; Maisonneuve, FJ; Robinson, SA, 2019
)
0.77

Dosage Studied

ExcerptRelevanceReference
" Dose-response analysis, leaching tests and a detailed transcriptome study were performed using highly KAR(1) -sensitive lettuce (Lactuca sativa cv 'Grand Rapids') achenes."( Molecular aspects of the antagonistic interaction of smoke-derived butenolides on the germination process of Grand Rapids lettuce (Lactuca sativa) achenes.
Balázs, E; Kohout, L; Light, ME; Posta, M; Sebestyén, E; Soós, V; Van Staden, J, 2012
)
0.62
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
butenolideA gamma-lactone that consists of a 2-furanone skeleton and its substituted derivatives.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (3)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Carbonic anhydrase 1Homo sapiens (human)Ki13.60000.00001.372610.0000AID639299
Carbonic anhydrase 2Homo sapiens (human)Ki100.00000.00000.72369.9200AID639300
Carbonic anhydrase 9Homo sapiens (human)Ki4.42000.00010.78749.9000AID639301
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (15)

Processvia Protein(s)Taxonomy
one-carbon metabolic processCarbonic anhydrase 1Homo sapiens (human)
morphogenesis of an epitheliumCarbonic anhydrase 2Homo sapiens (human)
positive regulation of synaptic transmission, GABAergicCarbonic anhydrase 2Homo sapiens (human)
positive regulation of cellular pH reductionCarbonic anhydrase 2Homo sapiens (human)
angiotensin-activated signaling pathwayCarbonic anhydrase 2Homo sapiens (human)
regulation of monoatomic anion transportCarbonic anhydrase 2Homo sapiens (human)
secretionCarbonic anhydrase 2Homo sapiens (human)
regulation of intracellular pHCarbonic anhydrase 2Homo sapiens (human)
neuron cellular homeostasisCarbonic anhydrase 2Homo sapiens (human)
positive regulation of dipeptide transmembrane transportCarbonic anhydrase 2Homo sapiens (human)
regulation of chloride transportCarbonic anhydrase 2Homo sapiens (human)
carbon dioxide transportCarbonic anhydrase 2Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 2Homo sapiens (human)
response to hypoxiaCarbonic anhydrase 9Homo sapiens (human)
morphogenesis of an epitheliumCarbonic anhydrase 9Homo sapiens (human)
response to xenobiotic stimulusCarbonic anhydrase 9Homo sapiens (human)
response to testosteroneCarbonic anhydrase 9Homo sapiens (human)
secretionCarbonic anhydrase 9Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 9Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (7)

Processvia Protein(s)Taxonomy
arylesterase activityCarbonic anhydrase 1Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 1Homo sapiens (human)
protein bindingCarbonic anhydrase 1Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 1Homo sapiens (human)
hydro-lyase activityCarbonic anhydrase 1Homo sapiens (human)
cyanamide hydratase activityCarbonic anhydrase 1Homo sapiens (human)
arylesterase activityCarbonic anhydrase 2Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 2Homo sapiens (human)
protein bindingCarbonic anhydrase 2Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 2Homo sapiens (human)
cyanamide hydratase activityCarbonic anhydrase 2Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 9Homo sapiens (human)
protein bindingCarbonic anhydrase 9Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 9Homo sapiens (human)
molecular function activator activityCarbonic anhydrase 9Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (10)

Processvia Protein(s)Taxonomy
cytosolCarbonic anhydrase 1Homo sapiens (human)
extracellular exosomeCarbonic anhydrase 1Homo sapiens (human)
cytoplasmCarbonic anhydrase 2Homo sapiens (human)
cytosolCarbonic anhydrase 2Homo sapiens (human)
plasma membraneCarbonic anhydrase 2Homo sapiens (human)
myelin sheathCarbonic anhydrase 2Homo sapiens (human)
apical part of cellCarbonic anhydrase 2Homo sapiens (human)
extracellular exosomeCarbonic anhydrase 2Homo sapiens (human)
cytoplasmCarbonic anhydrase 2Homo sapiens (human)
plasma membraneCarbonic anhydrase 2Homo sapiens (human)
apical part of cellCarbonic anhydrase 2Homo sapiens (human)
nucleolusCarbonic anhydrase 9Homo sapiens (human)
plasma membraneCarbonic anhydrase 9Homo sapiens (human)
membraneCarbonic anhydrase 9Homo sapiens (human)
basolateral plasma membraneCarbonic anhydrase 9Homo sapiens (human)
microvillus membraneCarbonic anhydrase 9Homo sapiens (human)
plasma membraneCarbonic anhydrase 9Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID639301Inhibition of human CA9 pre-incubated for 15 mins to 24 hrs measured after 6 hrs by phenol red-based stopped-flow CO2 hydrase assay2012Bioorganic & medicinal chemistry letters, Jan-01, Volume: 22, Issue:1
5- and 6-membered (thio)lactones are prodrug type carbonic anhydrase inhibitors.
AID639299Inhibition of human CA1 pre-incubated for 15 mins to 24 hrs measured after 6 hrs by phenol red-based stopped-flow CO2 hydrase assay2012Bioorganic & medicinal chemistry letters, Jan-01, Volume: 22, Issue:1
5- and 6-membered (thio)lactones are prodrug type carbonic anhydrase inhibitors.
AID71720Binding affinity towards [3H]GHB binding site at 10 uM1988Journal of medicinal chemistry, May, Volume: 31, Issue:5
Analogues of gamma-hydroxybutyric acid. Synthesis and binding studies.
AID639300Inhibition of human CA2 pre-incubated for 15 mins to 24 hrs measured after 6 hrs by phenol red-based stopped-flow CO2 hydrase assay2012Bioorganic & medicinal chemistry letters, Jan-01, Volume: 22, Issue:1
5- and 6-membered (thio)lactones are prodrug type carbonic anhydrase inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (339)

TimeframeStudies, This Drug (%)All Drugs %
pre-199018 (5.31)18.7374
1990's20 (5.90)18.2507
2000's97 (28.61)29.6817
2010's153 (45.13)24.3611
2020's51 (15.04)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 36.38

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index36.38 (24.57)
Research Supply Index5.84 (2.92)
Research Growth Index5.08 (4.65)
Search Engine Demand Index54.33 (26.88)
Search Engine Supply Index2.13 (0.95)

This Compound (36.38)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews10 (2.92%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other333 (97.08%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]